Cargando…

Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation

Middle east respiratory syndrome coronavirus (MERS-CoV) is a fatal pathogen that poses a serious health risk worldwide and especially in the middle east countries. Targeting the MERS-CoV 3-chymotrypsin-like cysteine protease (3CL(pro)) with small covalent inhibitors is a significant approach to inhi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alamri, Mubarak A., Tahir ul Qamar, Muhammad, Afzal, Obaid, Alabbas, Alhumaidi B., Riadi, Yassine, Alqahtani, Safar M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040153/ https://www.ncbi.nlm.nih.gov/pubmed/33867606 http://dx.doi.org/10.1016/j.molliq.2021.115699

Ejemplares similares

Novel and Potential Small Molecule Scaffolds as DYRK1A Inhibitors by Integrated Molecular Docking-Based Virtual Screening and Dynamics Simulation Study
por: Shahroz, Mir Mohammad, et al.
Publicado: (2022)

Molecular and Structural Analysis of Specific Mutations from Saudi Isolates of SARS-CoV-2 RNA-Dependent RNA Polymerase and their Implications on Protein Structure and Drug–Protein Binding
por: Alamri, Mubarak A., et al.
Publicado: (2022)

Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants
por: Tahir ul Qamar, Muhammad, et al.
Publicado: (2020)

CovalentDock Cloud: a web server for automated covalent docking
por: Ouyang, Xuchang, et al.
Publicado: (2013)

Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics
por: Alamri, Mubarak A., et al.
Publicado: (2020)

Covalent Docking of Large Libraries for the Discovery of Chemical Probes
por: London, Nir, et al.
Publicado: (2014)

Theory and Applications of Covalent Docking in Drug Discovery: Merits and Pitfalls
por: Kumalo, Hezekiel Mathambo, et al.
Publicado: (2015)

Discovery of human coronaviruses pan-papain-like protease inhibitors using computational approaches
por: Alamri, Mubarak A., et al.
Publicado: (2020)

Integrativesubtractive proteomics, immunoinformatics, docking, and simulation approaches reveal candidate vaccine against Sin Nombre orthohantavirus
por: Alabbas, Alhumaidi B.
Publicado: (2022)

Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands
por: Alamri, Mubarak A, et al.
Publicado: (2019)

Analyzing the effect of mutations in SARS-CoV2 papain-like protease from Saudi isolates on protein structure and drug-protein binding: Molecular modelling and dynamics studies
por: Alabbas, Alhumaidi B., et al.
Publicado: (2022)

Novel covalent and non-covalent complex-based pharmacophore models of SARS-CoV-2 main protease (M(pro)) elucidated by microsecond MD simulations
por: Hayek-Orduz, Yasser, et al.
Publicado: (2022)

Covalent flexible peptide docking in Rosetta
por: Tivon, Barr, et al.
Publicado: (2021)

Synthesis, Anticancer Screening of Some Novel Trimethoxy Quinazolines and VEGFR2, EGFR Tyrosine Kinase Inhibitors Assay; Molecular Docking Studies
por: Altamimi, Abdulmalik S., et al.
Publicado: (2021)

CovalentInDB: a comprehensive database facilitating the discovery of covalent inhibitors
por: Du, Hongyan, et al.
Publicado: (2020)

In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking
por: Vázquez-Mendoza, Luis Heriberto, et al.
Publicado: (2022)

Advances in covalent drug discovery
por: Boike, Lydia, et al.
Publicado: (2022)

Exploring potential SARS-CoV-2 Mpro non-covalent inhibitors through docking, pharmacophore profile matching, molecular dynamic simulation, and MM-GBSA
por: Shi, Yunfan, et al.
Publicado: (2023)

Prediction of Substrates for Glutathione Transferases by Covalent Docking
por: Dong, Guang Qiang, et al.
Publicado: (2014)

Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021)

Recent Advances in Covalent Drug Discovery
por: Schaefer, Daniel, et al.
Publicado: (2023)

Molecular determinants of acrylamide neurotoxicity through covalent docking
por: Mueller, Nicolas Pierre Friedrich, et al.
Publicado: (2023)

Correction: Fragment-based covalent ligand discovery
por: Lu, Wenchao, et al.
Publicado: (2021)

An update on the discovery and development of reversible covalent inhibitors
por: Faridoon, et al.
Publicado: (2023)

Covalent Docking Predicts Substrates for Haloalkanoate Dehalogenase Superfamily Phosphatases
por: London, Nir, et al.
Publicado: (2014)

Identification of novel STAT3 inhibitors for liver fibrosis, using pharmacophore-based virtual screening, molecular docking, and biomolecular dynamics simulations
por: Rafiq, Huma, et al.
Publicado: (2023)

Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking
por: Brindisi, Margherita, et al.
Publicado: (2015)

Covalent inhibitors: a rational approach to drug discovery
por: Sutanto, Fandi, et al.
Publicado: (2020)

Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening
por: Resnick, Efrat, et al.
Publicado: (2019)

Discovery of YopE Inhibitors by Pharmacophore-Based Virtual Screening and Docking
por: Ozbuyukkaya, Gizem, et al.
Publicado: (2013)

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
por: Pu, Yinglan, et al.
Publicado: (2017)

Chitosan Functionalization: Covalent and Non-Covalent Interactions and Their Characterization
por: Nicolle, Laura, et al.
Publicado: (2021)

Covalent and Non-covalent Functionalized Nanomaterials for Environmental Restoration
por: Zhang, Shizhong, et al.
Publicado: (2022)

Systematic Studies on the Protocol and Criteria for Selecting a Covalent Docking Tool
por: Wen, Chang, et al.
Publicado: (2019)

WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors
por: Scarpino, Andrea, et al.
Publicado: (2021)

Docking and Selectivity Studies of Covalently Bound Janus Kinase 3 Inhibitors
por: Zhong, Haizhen A., et al.
Publicado: (2023)

Docking covalent targets for drug discovery: stimulating the computer-aided drug design community of possible pitfalls and erroneous practices
por: Oyedele, Abdul-Quddus Kehinde, et al.
Publicado: (2022)

Novel 2-Sulfanylquinazolin-4(3H)-one Derivatives as Multi-Kinase Inhibitors and Apoptosis Inducers: A Synthesis, Biological Evaluation, and Molecular Docking Study
por: Altharawi, Ali, et al.
Publicado: (2023)

Identification of promising methionine aminopeptidase enzyme inhibitors: A combine study of comprehensive virtual screening and dynamics simulation study
por: Alabbas, Alhumaidi B.
Publicado: (2023)

Structure-Function Relationships of Covalent and Non-Covalent BTK Inhibitors
por: Zain, Rula, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fcgpt013l35q1o9c8aont4jvum